Table: Taisho Pharmaceutical HD -2015/16 parent results
May 16 (Reuters)-
Taisho Pharmaceutical Holdings Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Revenues 7.19 7.94
(-9.5 pct) (-71.0 pct)
Operating 5.74 5.63
(+2.0 pct) (-77.4 pct)
Recurring 5.67 5.55
(+2.2 pct) (-77.7 pct)
Net 4.05 3.89
(+4.1 pct) (-83.5 pct)
EPS 50.00 yen 47.94 yen
EPS Diluted 49.97 yen 47.92 yen
Ann Div 100.00 yen 110.00 yen 110.00 yen
-Q2 Div 50.00 yen 50.00 yen 50.00 yen
-Q4 Div 50.00 yen 60.00 yen 60.00 yen
NOTE - Taisho Pharmaceutical Holdings Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Taisho Pharmaceutical Holdings Co
See all newsBrief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Squeeze Out Price If Taisho Disagrees With Their Demand - Nikkei
Brief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Tender Offer Price If Taisho Disagrees Their Demand - Nikkei
Activist fund Oasis says it may take legal action over Taisho's management buyout
Brief: Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout
To Retire Treasury Shares Worth 3.65% Of Outstanding Stock On April 10